Education and Exercise via a Mobile App for Shoulder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Saskatchewan, Saskatoon, Canada
Shoulder+1 More
Education and Exercise via a Mobile App - Other
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

Breast cancer is the most common cancer for Canadian women. Of the women who will have a mastectomy each year in Canada, one in five will elect to have breast reconstruction. However, the significant benefits for body-image, self-esteem, sexuality, and quality of life are tempered by post-treatment shoulder dysfunction for many. As a means to decrease shoulder morbidities in breast cancer survivors (BCS), this study will introduce a mobile application (app)-based shoulder rehabilitation program as an option to improve functional outcomes of the shoulder, for those who have had breast reconstruction.

Eligible Conditions

  • Shoulder
  • Breast

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: At start of the study, at 4 weeks into the study and again at the end of the study (8 weeks into the study).

Week 8
Fatigue Assessment Scale (FAS)
Quick DASH (Disability of Arm, Shoulder and Hand)
Quick Disability of Arm, Shoulder and Hand (Quick DASH)
Short Form 36 (SF-36)
Shoulder Range of Motion (ROM)
Visual Analogue Scale (VAS)

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Education Group
1 of 2
Education plus Exercise Group
1 of 2
Active Control
Experimental Treatment

48 Total Participants · 2 Treatment Groups

Primary Treatment: Education and Exercise via a Mobile App · No Placebo Group · N/A

Education plus Exercise Group
Other
Experimental Group · 1 Intervention: Education and Exercise via a Mobile App · Intervention Types: Other
Education Group
Other
ActiveComparator Group · 1 Intervention: Education via a Mobile App · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at start of the study, at 4 weeks into the study and again at the end of the study (8 weeks into the study).
Closest Location: University of Saskatchewan · Saskatoon, Canada
Photo of saskatchewan 1Photo of saskatchewan 2Photo of saskatchewan 3
2007First Recorded Clinical Trial
0 TrialsResearching Shoulder
60 CompletedClinical Trials

Who is running the clinical trial?

Royal University Hospital FoundationOTHER
22 Previous Clinical Trials
6,823 Total Patients Enrolled
University of SaskatchewanLead Sponsor
233 Previous Clinical Trials
90,105 Total Patients Enrolled
Soo Kim, PhDPrincipal InvestigatorUniversity of Saskatchewan

Eligibility Criteria

Age 18+ · Female Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are scheduled for immediate or delayed breast reconstruction (implant type only).
You have had surgery within the last 6 weeks.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References